Table 1.

Patient Characteristics

Patient characteristic	% of Total patients (n = 93)	Mean % of cells staining w/EphA2 antibody (±SD)	Mean EphA2 antibody staining intensity (±SD)
Primary gleason grade
2	12	83 ± 2	2.0 ± 0.6
3	43	86 ± 10	2.3 ± 0.7
4	23	84 ± 16	2.3 ± 0.7
5	15	86 ± 11	2.3 ± 0.6
Secondary gleason grade
2	15	82 ± 16	2.3 ± 0.5
3	29	85 ± 15	2.1 ± 0.6
4	35	85 ± 9	2.3 ± 0.7
5	14	88 ± 8	2.4 ± 0.8
Gleason sum
<7	28	83 ± 12	2.2 ± 0.6
7	35	85 ± 14	2.2 ± 0.7
>7	30	87 ± 10	2.4 ± 0.7
T classification
T2a	9	89 ± 6	2.3 ± 0.5
T2b	43	84 ± 12	2.2 ± 0.7
T3a	27	84 ± 15	2.2 ± 0.7
T3b	14	63 ± 10	2.4 ± 0.6
Lymph node metastasis
Positive	13	88 ± 9	2.3 ± 0.6
Negative	80	84 ± 13	2.2 ± 0.7
Extraprostatic extension
Positive	53	86 ± 11	2.3 ± 0.7
Negative	40	84 ± 14	2.2 ± 0.7
Surgical margin
Positive	50	86 ± 11	2.1 ± 0.6
Negative	43	84 ± 13	2.4 ± 0.7
Vascular invasion
Positive	30	85 ± 11	2.1 ± 0.8
Negative	63	86 ± 13	2.3 ± 0.6
Perineural invasion
Positive	82	82 ± 15	2.4 ± 0.5
Negative	11	85 ± 12	2.2 ± 0.7
High-Grade PIN
Positive	89	85 ± 12	2.3 ± 0.7
Negative	4	85 ± 9	2.0 ± 0.8